EarningsCRBG's 4Q24 operating EPS was $1.23 versus consensus at $1.20, indicating a strong performance.
Growth PotentialCRBG is well positioned for the annuity growth thesis, supporting a Buy rating.
Shareholder ReturnsThe Board increased its repurchase authorization by $2 billion and raised its dividend by 4%, reflecting a commitment to returning value to shareholders.